Quarterly Result29 May 2026, 11:21 pm
Concord Drugs: FY26 Revenue ₹7,873.68 Lakhs
AI Summary
Concord Drugs Ltd announced its financial results for the year ending March 31, 2026. The company's revenue from operations stood at ₹7,873.68 lakhs. The Board of Directors approved the standalone and consolidated financial results in a meeting held on May 27, 2026. The profit for the period was ₹105.50 lakhs and earnings per share was ₹0.95.
Key Highlights
- Concord Drugs' revenue from operations for FY26 is ₹7,873.68 lakhs.
- The company's profit for the period ending March 31, 2026, was ₹105.50 lakhs.
- Basic earnings per share for FY26 stood at ₹0.95.
- Board approved standalone and consolidated financial results on May 27, 2026.